|
|
Latest Story |
Matinas BioPharma Prices $10 Million Registered Direct Offering |
GlobeNewswire |
Full Story → |
Headline News |
Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update |
4:05p ET March 27 '24 GlobeNewswire |
Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation |
8:00a ET March 25 '24 GlobeNewswire |
Three Patients with Invasive Fusarium Infection in Matinas BioPharma's Oral MAT2203 Compassionate/Expanded Use Access Program Achieve Complete Clinical Response |
9:15a ET March 22 '24 GlobeNewswire |
More News → |
|
April 24 '24. Markets Closed. | ||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Previous data from yesterday, April 23 '24. |